Cargando…
MYPT1 inhibits the metastasis of renal clear cell carcinoma via the MAPK8/N‐cadherin pathway
Myosin phosphatase target subunit 1 (MYPT1) is a subunit of myosin phosphatase that is capable of regulating smooth muscle contraction. MYPT1 has been reported to be involved in a wide variety of tumours, but its expression and biological functions in renal clear cell carcinoma (ccRCC) remain obscur...
Autores principales: | Xie, Qingling, Liu, Ren, Zou, Zhihao, Feng, Yuanfa, Huang, Yiqiao, Xu, Guibin, Sun, Wei, Liang, Yuxiang, Zhong, Weide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623519/ https://www.ncbi.nlm.nih.gov/pubmed/36106411 http://dx.doi.org/10.1002/2211-5463.13487 |
Ejemplares similares
-
A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism
por: Liu, Ren, et al.
Publicado: (2021) -
Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+ MYPT1 Expression
por: Ararat, Erhan, et al.
Publicado: (2009) -
KMT5A promotes metastasis of clear cell renal cell carcinoma through reducing cadherin-1 expression
por: Lin, Zhen-Zhong, et al.
Publicado: (2019) -
MYPT1 reduction is a pathogenic factor of erectile dysfunction
por: Zhao, Wei, et al.
Publicado: (2022) -
Overexpression of Myosin Phosphatase Target Subunit 1 (MYPT1) Inhibits Tumor Progression and Metastasis of Gastric Cancer
por: Wang, Fengyong, et al.
Publicado: (2018)